Specific behaviour ‐ agitation · patients with myocardial infarction
It is very uncertain whether lidocaine changes agitation compared with aprindine (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival at 30 days after myocardial infarction · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ventricular fibrillation · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (any type) and safety of sealant · patients with myocardial infarction
It is very uncertain whether lidocaine changes safety (AEs; adverse drug reaction): any adverse event compared with pirmenol (very low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): sinus bradycardia · patients with acute myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): sinus bradycardia compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): drowsiness/dizziness · patients with acute myocardial infarction
Lidocaine may leads to higher adverse events (AEs; adverse drug reaction): drowsiness/dizziness compared with placebo or no intervention (low certainty).
1 finding from 1 review
All‐cause mortality · patients with myocardial infarction
It is very uncertain whether lidocaine changes all‐cause mortality compared with disopyramide (very low certainty).
1 finding from 1 review
Cardiac mortality · patients with myocardial infarction
It is very uncertain whether lidocaine changes cardiac mortality compared with disopyramide (very low certainty).
1 finding from 1 review
Intervention not reported
Survival · patients with unresectable periampullary carcinoma
It is very uncertain whether the intervention changes survival (very low certainty).
1 finding from 1 review
Intervention not reported
Gastric outlet obstruction Clinical symptoms of vomiting with confirmation of the gastric outlet obstruction by radiological or endoscopic investigations · patients with unresectable periampullary carcinoma
It is very uncertain whether the intervention changes gastric outlet obstruction Clinical symptoms of vomiting with… (very low certainty).
1 finding from 1 review
Intervention not reported
Operating time · patients with unresectable periampullary carcinoma
1 finding from 1 review
Intervention not reported
Febrile neutropenia Rates of patients · breast cancer patients undergoing chemotherapy
The intervention probably leads to lower febrile neutropenia Rates of patients (moderate certainty).
1 finding from 1 review
Intervention not reported
Injection‐site reaction Rates of patients · breast cancer patients undergoing chemotherapy
The intervention probably leads to higher injection‐site reaction Rates of patients (moderate certainty).
1 finding from 1 review
Intervention not reported
Early mortality Rates of patients · breast cancer patients undergoing chemotherapy
The intervention may leads to lower early mortality Rates of patients (low certainty).
1 finding from 1 review
Intervention not reported
Infection‐related mortality Rates of patients · breast cancer patients undergoing chemotherapy
The intervention showed no clear difference in infection‐related mortality Rates of patients (low certainty).
1 finding from 1 review
Intervention not reported
Severe neutropenia (WHO grade IV) Rates of patients · breast cancer patients undergoing chemotherapy
The intervention showed no clear difference in severe neutropenia (WHO grade IV) Rates of patients (moderate certainty).
1 finding from 1 review
Intervention not reported
Infections Rates of patients · breast cancer patients undergoing chemotherapy
The intervention showed no clear difference in infections Rates of patients (low certainty).
1 finding from 1 review
Intervention not reported
Hospitalization Rates of patients · breast cancer patients undergoing chemotherapy
The intervention may leads to lower hospitalization Rates of patients (low certainty).
1 finding from 1 review